Table 2.
Characteristics | Group | p value | |
---|---|---|---|
OIT (N = 10) | Untreated (N = 6) | ||
Passed DBPCFC | 10/10 | 0/6 | <0.001 |
SCD of CMP at DBPCFC (mg) | |||
0 | 0 | 5 | <0.001 |
43 | 0 | 0 | |
130 | 0 | 1 | |
303 | 0 | 0 | |
650 | 0 | 0 | |
1340 | 0 | 0 | |
2080 | 10 | 0 | |
Grade of allergic reaction at DBPCFC # | |||
0 | 10 | 0 | <0.001 |
1 | 0 | 3 | |
2 | 0 | 3 | |
3 | 0 | 0 | |
4 | 0 | 0 | |
Passed fresh CM OFC | 7/10 | 0/6 | 0.01136 |
SCD of CM at OFC (mL) | |||
0 | 0 | 6 | 0.006 |
15 | 0 | 0 | |
45 | 0 | 0 | |
105 | 3 | 0 | |
200 | 7 | 0 | |
Grade of allergic reaction at DBPCFC # | |||
0 | 7 | 0 | 0.075 |
1 | 0 | 0 | |
2 | 1 | 6 | |
3 | 2 | 0 | |
4 | 0 | 0 |
#Grade of anaphylaxis according to Sampson’s grading score24 OIT: oral immunotherapy, SCD: successfully consumed dose, CMP: cow’s milk protein, DBPCFC: double-blind placebo controlled food challenge, CM: cow’s milk, OFC: open food challenge, IQR: interquartile range, CS: casein, β-lact: β-lactoglobulin, α-lact: α-lactoalbumin.